Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neurocrine Bioscienc
(NQ:
NBIX
)
145.44
UNCHANGED
Streaming Delayed Price
Updated: 4:15 PM EDT, Jul 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
145.44
Bid (Size)
138.01 (1)
Ask (Size)
153.82 (1)
Prev. Close
145.44
Today's Range
145.44 - 145.44
52wk Range
98.53 - 150.39
Shares Outstanding
100,600,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
July 10, 2024
Via
Benzinga
Why NASDAQ:NBIX Is a Promising High-Growth Stock in the Midst of Consolidation.
July 05, 2024
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX), a strong growth stock, setting up for a breakout.
Via
Chartmill
Performance
YTD
+10.41%
+10.41%
1 Month
+8.85%
+8.85%
3 Month
+3.82%
+3.82%
6 Month
+3.58%
+3.58%
1 Year
+45.41%
+45.41%
More News
Read More
NASDAQ:NBIX is not too expensive for the growth it is showing.
July 05, 2024
Via
Chartmill
Reasonable Growth, Debt Levels, and a High ROIC Make NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Appealing to Quality Investors.
July 04, 2024
Via
Chartmill
Despite its impressive fundamentals, NASDAQ:NBIX remains undervalued.
June 20, 2024
Via
Chartmill
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
June 17, 2024
Via
InvestorPlace
Key Takeaways From Neurocrine Biosciences Analyst Ratings
May 28, 2024
Via
Benzinga
Exploring NASDAQ:NBIX's quality characteristics.
May 27, 2024
Via
Chartmill
Exploring the Growth Potential of NASDAQ:NBIX as It Nears a Breakout.
May 24, 2024
Via
Chartmill
Is NASDAQ:NBIX on the Verge of a Major Breakout as a Strong Growth Stock?
June 14, 2024
Via
Chartmill
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
June 14, 2024
Via
Investor's Business Daily
Don't overlook NASDAQ:NBIX—a stock with solid growth prospects and a reasonable valuation.
June 13, 2024
Via
Chartmill
In the world of growth stocks, NASDAQ:NBIX shines as a value proposition.
May 23, 2024
Via
Chartmill
Nvidia Leads Five Stocks Near Buy Points As Market Rally Picks Up Steam
May 04, 2024
Via
Investor's Business Daily
A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
May 03, 2024
Via
Investor's Business Daily
Why Quality Investors May Find NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Attractive.
May 03, 2024
Via
Chartmill
NASDAQ:NBIX, a strong growth stock, setting up for a breakout.
May 02, 2024
Via
Chartmill
Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review
May 03, 2024
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Despite its growth, NASDAQ:NBIX remains within the realm of affordability.
May 02, 2024
Via
Chartmill
PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
May 01, 2024
Via
Investor's Business Daily
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
May 01, 2024
Via
Benzinga
NBIX Stock Earnings: Neurocrine Biosciences Beats EPS, Beats Revenue for Q1 2024
May 01, 2024
Via
InvestorPlace
No. 1 Biotech Stock Neurocrine Pops After Its Biggest Moneymaker Snatches Another Win
May 01, 2024
Via
Investor's Business Daily
Sarepta Therapeutics Stock Shows Improved Technical Strength
April 29, 2024
Via
Investor's Business Daily
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
April 26, 2024
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
